1 Department of Infectious Diseases, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, The First Affiliated Hospital, School of Medicine, Zhejiang University, China.
Both contributed equally to this work.
Cell Transplant. 2019 Aug;28(8):1033-1038. doi: 10.1177/0963689719840025. Epub 2019 Mar 29.
To determine whether non-alcoholic fatty liver disease (NAFLD) and intracerebral hemorrhage (ICH) are connected, and assess the role played by NAFLD in ICH development. A retrospective study evaluated inpatients treated at the First Affiliated Hospital of Zhejiang University. We divided the patients into Group A (ICH with NAFLD) and Group B (ICH alone). Moreover, univariate and multivariate logistic regression analyses were performed to identify the risk factors for unfavorable outcomes. A total of 128 patients were included: 34 ICH with NAFLD (group A) and 94 ICH (group B). Sixteen patients exhibited an unfavorable outcome. There was no significant difference among the two groups on the underlying diseases hypertension and heart disease. Group A had more diabetes mellitus cases (35.29% vs 12.76%, = 0.004). Levels of alanine aminotransferase and triglyceride were higher in group A than in group B (all < 0.05), while differences in other blood biochemistry tests were statistically insignificant (all > 0.05). There was a similarity in bleeding sites except for brainstem hemorrhage, which was higher in group B patients ( = 0.036). Multivariate logistic regression analysis revealed that low-density lipoprotein (OR, 0.278; 95% CI (0.107-0.702), = 0.008) was a protective factor for ICH patients with NAFLD. The National Institute of Health Stroke Scale (NIHSS) score at discharge (OR, 3.152; 95% CI (1.532-6.486), = 0.002) was independent of risk factors for unfavorable outcomes. Serum levels of LDL was a protective factor. NAFLD did not increase the unfavorable outcome of ICH patients in our study.
为了确定非酒精性脂肪性肝病(NAFLD)和脑出血(ICH)是否有关,并评估 NAFLD 在 ICH 发展中的作用,我们进行了一项回顾性研究,评估了在浙江大学第一附属医院接受治疗的住院患者。我们将患者分为 A 组(ICH 合并 NAFLD)和 B 组(单纯 ICH)。此外,还进行了单因素和多因素 logistic 回归分析,以确定不良结局的危险因素。共纳入 128 例患者:34 例 ICH 合并 NAFLD(A 组)和 94 例 ICH(B 组)。16 例患者预后不良。两组基础疾病高血压和心脏病无显著差异。A 组糖尿病病例较多(35.29%比 12.76%, = 0.004)。A 组丙氨酸氨基转移酶和甘油三酯水平高于 B 组(均 < 0.05),而其他血液生化检查差异无统计学意义(均 > 0.05)。除脑干出血外,两组出血部位相似( = 0.036)。多因素 logistic 回归分析显示,低密度脂蛋白(OR,0.278;95%CI(0.107-0.702), = 0.008)是合并 NAFLD 的 ICH 患者的保护因素。出院时国立卫生研究院卒中量表(NIHSS)评分(OR,3.152;95%CI(1.532-6.486), = 0.002)是不良结局的独立危险因素。血清 LDL 水平是保护因素。在我们的研究中,NAFLD 并未增加 ICH 患者的不良预后。